The effect of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide on tolerance to morphine and alcohol in mice

Ann N Y Acad Sci. 1998 Dec 11:865:566-9. doi: 10.1111/j.1749-6632.1998.tb11238.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesia
  • Animals
  • Body Temperature Regulation / drug effects
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology*
  • Drug Implants
  • Drug Tolerance
  • Ethanol / administration & dosage
  • Ethanol / pharmacology*
  • Injections, Intraperitoneal
  • Injections, Intraventricular
  • Injections, Subcutaneous
  • Male
  • Mice
  • Mice, Inbred Strains
  • Morphine / administration & dosage
  • Morphine / pharmacology*
  • Neuropeptides / administration & dosage
  • Neuropeptides / pharmacology*
  • Pain / physiopathology*
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Reflex / drug effects
  • Reflex / physiology
  • Vasoactive Intestinal Peptide / administration & dosage
  • Vasoactive Intestinal Peptide / pharmacology*

Substances

  • Adcyap1 protein, mouse
  • Drug Implants
  • Neuropeptides
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Vasoactive Intestinal Peptide
  • Ethanol
  • Morphine